Crossing the Same River Multiple Times

Every year, the editors of Pharmaceutical Technology Europe conduct a survey (1) designed to measure the state of the bio/pharma industry. The editors selected several intriguing areas of opportunities for participants to choose between, and as shown in Figure 8, just under half (47.3%) chose cell a...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2023-01, Vol.35 (1), p.12-14
Main Author: Playter, Grant
Format: Article
Language:English
Subjects:
Artificial intelligence
COVID-19 vaccines
Employees
Employment
Employment security
Job satisfaction
Pandemics
Pharmaceutical industry
Pharmaceutical sciences
Polls & surveys
Raises
Trends
Wages & salaries
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Every year, the editors of Pharmaceutical Technology Europe conduct a survey (1) designed to measure the state of the bio/pharma industry. The editors selected several intriguing areas of opportunities for participants to choose between, and as shown in Figure 8, just under half (47.3%) chose cell and gene therapies. In addition to cell and gene therapies, machine learning and artificial intelligence (22.3%) also drew significant interest from the survey population.
ISSN:1753-7967